Pulmatrix: Pulmatrix Announces Third Quarter 2022 Financial Results and Provides Corporate Update
Pulmatrix, Inc. today announced third quarter financial results for 2022 and provided a corporate update related to its development programs.
Read full article »
Pulmatrix is a Massachusetts-based biopharmaceutical firm that develops and commercializes therapies for the treatment of pulmonary and non-pulmonary diseases.
Read more